Raymond James Financial Services Advisors’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-34,569	Closed	-$71K	–	3122
2020 Q3	$71K	Buy	34,569 +11,869	+52%	+$33.9K	﹤0.01%	2733
2020 Q2	$67K	Buy	22,700 +2,500	+12%	+$6.83K	﹤0.01%	2687
2020 Q1	$53K	Buy	20,200 +2,000	+11%	+$9.01K	﹤0.01%	2310
2019 Q4	$90K	Sell	18,200 -55	-0.3%	-$298	﹤0.01%	2713
2019 Q3	$109K	Buy	+18,255	New	+$122K	﹤0.01%	2621

Other funds holding ETTX

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Raymond James Financial Services Advisors's ETTX Position: Q4 2020 in Review

Raymond James Financial Services Advisors sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q4 2020, closing a stake of 34,569 shares — an estimated $71K sold.

Raymond James Financial Services Advisors first reported a position in ETTX in Q3 2019 and held it in 5 quarters. The position peaked at $109K in Q3 2019. 25 funds tracked by Wall St. Rank hold ETTX as of Q4 2020.

Raymond James Financial Services Advisors reported no remaining Entasis Therapeutics Holdings Inc. position as of Q4 2020 after selling out during the quarter.
Raymond James Financial Services Advisors sold 34,569 Entasis Therapeutics Holdings Inc. shares in Q4 2020, an estimated $71K.
Raymond James Financial Services Advisors first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2019 and held it in 5 quarters.
Raymond James Financial Services Advisors's Entasis Therapeutics Holdings Inc. position peaked at $109K in Q3 2019.
25 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q4 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.